Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Altimmune
Biotech
GSK chief steps down in stunning move—Chutes & Ladders
GSK chief steps down in stunning move. Cue queues up CEO transition. Quotient adds experienced drug developer.
Darren Incorvaia
,
Zoey Becker
Oct 3, 2025 8:30am
Altimmune stock sinks on mixed ph. 2 MASH results for GLP-1 drug
Jun 26, 2025 8:41am
Altimmune touts 'best-in-class' lean mass data in weight loss
Jun 23, 2024 1:45pm
Altimmune bails on hepatitis B after phase 2 data disappoint
Mar 27, 2024 7:57am
As Madrigal lands MASH nod, what's next for biotechs in pursuit?
Mar 15, 2024 10:55am
Altimmune puts heart health at center of phase 2 obesity data
Dec 1, 2023 8:18am